Karl P. Flora

Taxol: a history of pharmaceutical development and current pharmaceutical concerns.

Jonathan D. Adams, Karl P. Flora, Barry R. Goldspiel et al. · PubMed · 1993 · 159 citations

Medicinal Chemistry, Pharmaceutical Science, Pharmaceutical Research +15

Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity

Gurpreet S. Ahluwalia, David A. Cooney, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1987 · 147 citations

Molecular Pharmacology, Hiv Infectivity, Medicine +9

Stability studies: five years later.

Lawrence A. Trissel, Karl P. Flora · PubMed · 1988 · 80 citations

Bioequivalence, Stability Studies, Pharmacology +11

Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions

Yuen-Wah Cheung, James C. Cradock, B. Rao Vishnuvajjala et al. · American Journal of Health-System Pharmacy · 1987 · 66 citations

Intravenous Solutions, Pharmaceutical Science, Sodium Chloride Concentrations +18

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins

Seiji Kageyama, Barry Anderson, Barbara L. Hoesterey et al. · Antimicrobial Agents and Chemotherapy · 1994 · 63 citations · Full text

High Concentrations, Immunology, Antiviral Drug +19